Herbalife Shares Surge 15% as Cristiano Ronaldo Invests $7.5M in AI Wellness Platform

Cristiano Ronaldo has acquired a 10% stake in HBL Pro2col Software, Herbalife’s artificial intelligence-driven wellness platform, through a $7.5 million investment announced February 19, 2026.

The deal combines direct capital with Ronaldo’s ongoing promotional commitment as a long-standing Herbalife brand ambassador since 2013. The Portuguese football star described the move as a logical extension of his interest in health technology, stating he aims to help shape the future of personalized wellness solutions.

HBL Pro2col integrates AI algorithms, biometric data from wearables, nutrition tracking, and user inputs to generate tailored health and fitness plans. The platform’s proprietary Pro2Score metric evaluates overall wellness progress across physical, nutritional, and lifestyle factors, offering real-time feedback and adjustments.

Strategic Shift and Market Performance

Herbalife positions Pro2col as a key element in its shift toward tech-enabled nutrition and performance products. The company reported strong Q4 2025 sales growth in its latest earnings, driven by demand for science-backed supplements and digital tools. The Ronaldo investment is expected to accelerate global rollout, particularly in markets where the ambassador’s influence is strongest.

Following the announcement, Herbalife Nutrition Inc. (NYSE: HLF) shares rose 16.5% to close at $19.27, reflecting investor optimism about the partnership’s potential to attract new users and boost brand credibility in the competitive wellness-tech sector.

Expanding Personal Portfolio

Ronaldo’s involvement builds on his history of strategic investments outside football, including hotel properties, gyms, and other health-related ventures. As one of the most-followed athletes globally, his endorsement and equity stake are viewed as a powerful marketing lever for Herbalife, which has faced challenges in recent years amid regulatory scrutiny and shifting consumer preferences in the nutrition industry.

Herbalife executives highlighted that the collaboration will include co-branded content, product development input from Ronaldo’s fitness regimen, and expanded access to Pro2col features for his fan base. The platform is already available in select markets and is scheduled for wider international launch in 2026.

The transaction values the HBL Pro2col business unit at $75 million post-money, with Ronaldo’s stake reflecting both financial commitment and strategic alignment. This move comes at a time when AI-powered health platforms are gaining traction, with competitors including Whoop, Levels, Oura, and Lumen also leveraging biometrics and machine learning for personalized insights.